Steve Gleason

Dr Angela Genge
Executive Director, Clinical Research Unit, Montreal Neurological Institute and Hospital

Talk title: "ALS Drug Development Programs 2021: Overview of the international ALS drug development programs with the integration of Biomarkers in Early Phase development programs"

Dr. Angela Genge has been the Director of the Clinical Research Unit at the Montreal Neurological Institute since 2004. Her expertise and ground-breaking work in the introduction of innovative therapies in the rare disease space has led her to be a sought-after member of numerous advisory boards for companies developing therapies for these diseases. Clinically, she is the Director of the Neuro ALS clinical program and multidisciplinary clinic, and a neuromuscular neurologist.  Throughout her career she has received numerous awards, most recently the 2018 Forbes Norris Award, the DIVA of Distinction Award, and the Governor General Diamond Jubilee Award.